IL97917A0 - Pharmaceutical compositions comprising tnf - Google Patents

Pharmaceutical compositions comprising tnf

Info

Publication number
IL97917A0
IL97917A0 IL97917A IL9791791A IL97917A0 IL 97917 A0 IL97917 A0 IL 97917A0 IL 97917 A IL97917 A IL 97917A IL 9791791 A IL9791791 A IL 9791791A IL 97917 A0 IL97917 A0 IL 97917A0
Authority
IL
Israel
Prior art keywords
tnf
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
IL97917A
Other languages
English (en)
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of IL97917A0 publication Critical patent/IL97917A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL97917A 1990-04-23 1991-04-22 Pharmaceutical compositions comprising tnf IL97917A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51128190A 1990-04-23 1990-04-23

Publications (1)

Publication Number Publication Date
IL97917A0 true IL97917A0 (en) 1992-06-21

Family

ID=24034226

Family Applications (1)

Application Number Title Priority Date Filing Date
IL97917A IL97917A0 (en) 1990-04-23 1991-04-22 Pharmaceutical compositions comprising tnf

Country Status (9)

Country Link
US (1) US5580555A (xx)
EP (1) EP0455093A3 (xx)
JP (1) JPH08169843A (xx)
KR (1) KR910018031A (xx)
AU (1) AU644156B2 (xx)
CA (1) CA2040965A1 (xx)
IE (1) IE911318A1 (xx)
IL (1) IL97917A0 (xx)
ZA (1) ZA913036B (xx)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5948384A (en) * 1990-09-14 1999-09-07 Syngenix Limited Particulate agents
GB9020075D0 (en) 1990-09-14 1990-10-24 Filler Aaron G Contrast agents for magnetic resonance imaging of axonal transport
US6919067B2 (en) 1991-09-13 2005-07-19 Syngenix Limited Compositions comprising a tissue glue and therapeutic agents
WO1994011384A1 (en) * 1992-11-13 1994-05-26 Immunex Corporation Novel cytokine designated elk ligand
US6303769B1 (en) 1994-07-08 2001-10-16 Immunex Corporation Lerk-5 dna
US6479053B1 (en) 1997-10-23 2002-11-12 President And Fellows Of Harvard College Laser inactivation of inhibitory molecules in central nervous system myelin
IL124722A0 (en) * 1998-06-02 1999-01-26 Oron Amir Ischemia laser treatment
AU2001237939A1 (en) * 2000-02-08 2001-08-20 Gulgun Tezel Methods for treating glaucoma
US7534255B1 (en) 2003-01-24 2009-05-19 Photothera, Inc Low level light therapy for enhancement of neurologic function
US8308784B2 (en) 2006-08-24 2012-11-13 Jackson Streeter Low level light therapy for enhancement of neurologic function of a patient affected by Parkinson's disease
US7303578B2 (en) 2001-11-01 2007-12-04 Photothera, Inc. Device and method for providing phototherapy to the brain
US9993659B2 (en) 2001-11-01 2018-06-12 Pthera, Llc Low level light therapy for enhancement of neurologic function by altering axonal transport rate
US10683494B2 (en) 2001-11-01 2020-06-16 Pthera LLC Enhanced stem cell therapy and stem cell production through the administration of low level light energy
US20030109906A1 (en) * 2001-11-01 2003-06-12 Jackson Streeter Low level light therapy for the treatment of stroke
US10695577B2 (en) 2001-12-21 2020-06-30 Photothera, Inc. Device and method for providing phototherapy to the heart
US7316922B2 (en) 2002-01-09 2008-01-08 Photothera Inc. Method for preserving organs for transplant
US7344555B2 (en) 2003-04-07 2008-03-18 The United States Of America As Represented By The Department Of Health And Human Services Light promotes regeneration and functional recovery after spinal cord injury
US7575589B2 (en) 2006-01-30 2009-08-18 Photothera, Inc. Light-emitting device and method for providing phototherapy to the brain
US20090254154A1 (en) 2008-03-18 2009-10-08 Luis De Taboada Method and apparatus for irradiating a surface with pulsed light
US10357662B2 (en) 2009-02-19 2019-07-23 Pthera LLC Apparatus and method for irradiating a surface with light
US7848035B2 (en) 2008-09-18 2010-12-07 Photothera, Inc. Single-use lens assembly
US9950189B1 (en) * 2016-10-20 2018-04-24 Neuro-Laser Foundation Inc. Treatment methodologies using light therapy
US10905897B2 (en) * 2016-10-20 2021-02-02 Neuro-Laser Foundation, Inc. Synergistic treatment methodologies using light therapy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3214667C2 (de) * 1982-04-21 1985-07-18 Akzo Gmbh, 5600 Wuppertal Zusammengesetzter Körper für die Langzeitabgabe von Wirkstoffen
US4879111A (en) * 1986-04-17 1989-11-07 Cetus Corporation Treatment of infections with lymphokines
US4808402A (en) * 1987-05-29 1989-02-28 Northwestern University Method and compositions for modulating neovascularization
IL82830A (en) * 1987-06-09 1992-03-29 Simeone Rochkind Apparatus for inducing functional regeneration of nerve fibres at an injured site of the spinal cord
IL87349A (en) * 1988-08-04 1994-06-24 Michal Schwartz A water-soluble agent that activates AILG cells, its preparation and the pharmaceutical preparations that contain it
IL91459A0 (en) * 1989-08-28 1990-04-29 Yeda Res & Dev Oligodendrocyte inhibitory factor

Also Published As

Publication number Publication date
ZA913036B (en) 1992-01-29
IE911318A1 (en) 1991-10-23
EP0455093A2 (en) 1991-11-06
AU644156B2 (en) 1993-12-02
CA2040965A1 (en) 1991-10-24
JPH08169843A (ja) 1996-07-02
EP0455093A3 (en) 1992-01-29
AU7537191A (en) 1991-10-24
US5580555A (en) 1996-12-03
KR910018031A (ko) 1991-11-30

Similar Documents

Publication Publication Date Title
IL97917A0 (en) Pharmaceutical compositions comprising tnf
GB9115893D0 (en) Pharmaceutical compositions
GB9100465D0 (en) Pharmaceutical compositions
GB9111314D0 (en) Pharmaceutical compositions
GB9122083D0 (en) Pharmaceutical compositions
GB9115693D0 (en) Solid pharmaceutical compositions
GB9115596D0 (en) Pharmaceutical compositions
GB9026080D0 (en) Pharmaceutical compositions
GB9120672D0 (en) Pharmaceutical compositions
GB9003185D0 (en) Pharmaceutical compositions
ZA917596B (en) Pharmaceutical compositions
GB9121631D0 (en) Pharmaceutical compositions
GB9015435D0 (en) Pharmaceutical compositions
GB9015418D0 (en) Pharmaceutical compositions
GB9200414D0 (en) Pharmaceutical compositions
GB9413572D0 (en) Pharmaceutical compositions
ZW10690A1 (en) Pharmaceutical compositions
GB9026882D0 (en) Pharmaceutical compositions
IL94075A0 (en) Pharmaceutical compositions
GB9026476D0 (en) Pharmaceutical compositions
GB9026391D0 (en) Pharmaceutical compositions
GB9027605D0 (en) Pharmaceutical compositions
GB9023655D0 (en) Pharmaceutical compositions
GB9002351D0 (en) Pharmaceutical compositions
GB9022025D0 (en) Pharmaceutical compositions